Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

121 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
[Malignant melanoma of the skin].
Simon JC, Grimme H, Bergen E, Vanscheidt W, Schöpf E. Simon JC, et al. Among authors: bergen e. Fortschr Med. 1995 Oct 10;113(28):393-6. Fortschr Med. 1995. PMID: 7498864 Review. German.
Dacarbazine and interferon alpha for stage IV malignant melanoma.
Tamm I, Grimme H, Bergen E, Simon JC, Schöpf E, Mertelsmann R, Lindemann A, Brennscheidt U. Tamm I, et al. Among authors: bergen e. Oncology. 1997 Jul-Aug;54(4):270-4. doi: 10.1159/000227701. Oncology. 1997. PMID: 9216849 Clinical Trial.
Postoperative CMF Does Not Ameliorate Poor Outcomes in Women With Residual Invasive Breast Cancer After Neoadjuvant Epirubicin/Docetaxel Chemotherapy.
Promberger R, Dubsky P, Mittlböck M, Ott J, Singer C, Seemann R, Exner R, Panhofer P, Steger G, Bergen E, Gnant M, Jakesz R, Bago-Horvath Z, Rudas M, Bartsch R. Promberger R, et al. Among authors: bergen e. Clin Breast Cancer. 2015 Dec;15(6):505-11. doi: 10.1016/j.clbc.2015.06.007. Epub 2015 Jun 18. Clin Breast Cancer. 2015. PMID: 26195436
Favourable outcome of patients with breast cancer brain metastases treated with dual HER2 blockade of trastuzumab and pertuzumab.
Bergen ES, Binter A, Starzer AM, Heller G, Kiesel B, Tendl-Schulz K, Bago-Horvath Z, Furtner J, Leitner J, Exner R, Fitzal F, Dieckmann K, Widhalm G, Preusser M, Berghoff AS, Bartsch R. Bergen ES, et al. Ther Adv Med Oncol. 2021 Apr 22;13:17588359211009002. doi: 10.1177/17588359211009002. eCollection 2021. Ther Adv Med Oncol. 2021. PMID: 33995593 Free PMC article.
Androgen Receptor is Expressed in Breast Cancer Brain Metastases.
Bergen ES, Berghoff AS, Steindl A, Rajky O, Mercea PA, Kiesel B, Tendl-Schulz K, Bago-Horvath Z, Exner R, Fitzal F, Dieckmann K, Widhalm G, Steger GG, Preusser M, Bartsch R. Bergen ES, et al. Appl Immunohistochem Mol Morphol. 2021 Nov-Dec 01;29(10):728-733. doi: 10.1097/PAI.0000000000000952. Appl Immunohistochem Mol Morphol. 2021. PMID: 34121071 Clinical Trial.
Trastuzumab deruxtecan in HER2-positive breast cancer with brain metastases: a single-arm, phase 2 trial.
Bartsch R, Berghoff AS, Furtner J, Marhold M, Bergen ES, Roider-Schur S, Starzer AM, Forstner H, Rottenmanner B, Dieckmann K, Bago-Horvath Z, Haslacher H, Widhalm G, Ilhan-Mutlu A, Minichsdorfer C, Fuereder T, Szekeres T, Oehler L, Gruenberger B, Singer CF, Weltermann A, Puhr R, Preusser M. Bartsch R, et al. Nat Med. 2022 Sep;28(9):1840-1847. doi: 10.1038/s41591-022-01935-8. Epub 2022 Aug 8. Nat Med. 2022. PMID: 35941372 Free PMC article. Clinical Trial.
Prognostic impact of breast cancer subtypes in elderly patients.
Bergen ES, Tichy C, Berghoff AS, Rudas M, Dubsky P, Bago-Horvath Z, Mader RM, Exner R, Gnant M, Zielinski CC, Steger GG, Preusser M, Bartsch R. Bergen ES, et al. Breast Cancer Res Treat. 2016 May;157(1):91-9. doi: 10.1007/s10549-016-3787-y. Epub 2016 Apr 23. Breast Cancer Res Treat. 2016. PMID: 27107570 Free PMC article.
121 results